Essai de phase III randomisé, multicentrique et en ouvert COMMODORE 1 : comparaison du crovalimab et de l’éculizumab chez des patients atteints d’hémoglobinurie paroxystique nocturne (HPN) déjà traités par un inhibiteur du complément
Year: 2024
Type: article
Study design: Clinical Trial
Source: La Revue de Médecine Interne
Authors: C. Tessier, L. Terriou, P. Scheinberg, D. Villa Clé, J.R. Edwards, V. Giai, M. Hus, J. Kim, C. Barrenetxea Lekue, Z. Nagy, E. Nur, J. Panse, Y. Ueda, M. Yenerel, A. Appius, N. Balachandran, S. Chebon, B. Gentile, S. Buatois, A. Kulasekararaj
Institutions: Roche (France), Hôpital Claude Huriez, Beneficência Portuguesa de São Paulo, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Medical University of Lublin, Yonsei University, Semmelweis University, Amsterdam University Medical Centers, Amsterdam UMC Location Vrije Universiteit Amsterdam, RWTH Aachen University, The University of Osaka, Istanbul University, Roche (Switzerland), Roche (United Kingdom), Genentech, King's College London, King's College Hospital
Language: French
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4404761006